Share-Based Compensation - Additional Information (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Aug. 01, 2026 |
Aug. 02, 2025 |
Aug. 01, 2026 |
Aug. 02, 2025 |
Jun. 01, 2023 |
Oct. 01, 2020 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
| Equity compensation expense | $ 9.3 | $ 7.6 | $ 20.4 | $ 15.1 | ||
| ESPP | ||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
| Common stock reserved for future issuance (in shares) | 2,000,000 | 2,000,000 | ||||
| Common stock authorized for grant (in shares) | 1,271,482 | 1,271,482 | ||||
| Common stock available for grant (in shares) | 1,271,482 | 1,271,482 | ||||
| 2020 Share Incentive Plan | ||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
| Common stock reserved for future issuance (in shares) | 2,600,000 | 5,150,000 | ||||
| Common stock authorized for grant (in shares) | 2,889,110 | 2,889,110 | ||||
| Common stock available for grant (in shares) | 2,889,110 | 2,889,110 | ||||
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|